DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Leukopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Leukopenia (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include leukopenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-20

Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epirubicin
    Start date: 2012-05-17
    End date: 2012-05-18

Ifosfamide
    Start date: 2012-05-17
    End date: 2012-05-18

Mesna
    Start date: 2012-05-17
    End date: 2012-05-18

Epirubicin
    Start date: 2012-05-17
    End date: 2012-05-18

Epirubicin
    Start date: 2012-05-17
    End date: 2012-05-18



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-06

Patient: 49 year old female

Reactions: Erythema Infectiosum, Hepatitis Acute, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Epirubicin
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine Sulfate
    Indication: Diffuse Large B-Cell Lymphoma

Dexamethasone
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Lamivudine



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-03

Patient: 49 year old female

Reactions: Erythema Infectiosum, Hepatitis Acute, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Epirubicin
    Dosage: 6-cycles
    Indication: Intestinal T-Cell Lymphoma

Cyclophosphamide
    Dosage: 6 cycles
    Indication: Intestinal T-Cell Lymphoma

Vincristine
    Dosage: 6-cycles
    Indication: Intestinal T-Cell Lymphoma

Rituximab
    Indication: Intestinal T-Cell Lymphoma

Dexamethasone
    Dosage: 6-cycles
    Indication: Intestinal T-Cell Lymphoma

Other drugs received by patient: Lamivudine



Possible Epirubicin side effects in female

Reported by a physician from Germany on 2012-03-09

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: General Physical Health Deterioration, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: unk
    Start date: 2010-02-12

NO Treatment Received
    Dosage: not treatment

Cyclophosphamide
    Dosage: unk
    Start date: 2010-02-12

Docetaxel
    Dosage: unk
    Start date: 2010-02-12

Other drugs received by patient: Emend; Ciprofloxacin; Granisetron Hydrochloride; Neulasta; Dexamethasone; Mesna



Possible Epirubicin side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-08

Patient: 52 year old female

Reactions: Hypovolaemic Shock, Intestinal Ischaemia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
(Tevagrastim)
    Dosage: 34 ug microgram(s) subcutaneous
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-25
    End date: 2012-01-28

Epirubicin
    Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
    Indication: Breast Cancer
    Start date: 2011-12-30

Epirubicin
    Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
    Indication: Breast Cancer
    Start date: 2012-01-20
    End date: 2012-01-20

Docetaxel
    Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
    Indication: Breast Cancer
    Start date: 2011-12-30

Docetaxel
    Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
    Indication: Breast Cancer
    Start date: 2012-01-20
    End date: 2012-01-20

Other drugs received by patient: (Trimeton / 0072502 / ); Zofran; Dexamethasone Sodium Phosphate; (Ranidil); Emend



Possible Epirubicin side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-28

Patient: 52 year old female

Reactions: Intestinal Ischaemia, Hypovolaemic Shock, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
(Tevagastrim)
    Dosage: 345 ug microgram(s), subcutaneous
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-25
    End date: 2012-01-28

Docetaxel
    Dosage: 136 mg milligram(s) intravenous (not otherwise specified)
    Indication: Breast Cancer
    Start date: 2012-01-20
    End date: 2012-01-20

Epirubicin
    Dosage: 136 mg milligram(s) intravenous (not otherwise specified)
    Indication: Breast Cancer
    Start date: 2012-01-20
    End date: 2012-01-20

Other drugs received by patient: (Soldesman); (Ranidil); (Trimeton / 00072502 / ); Emend; Zofran



Possible Epirubicin side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-23

Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Carboplatin
    Dosage: 400 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

Fluorouracil
    Dosage: 330 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

Etoposide
    Dosage: 70 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

Epirubicin
    Dosage: 27 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer



Possible Epirubicin side effects in female

Reported by a physician from Germany on 2011-11-18

Patient: female

Reactions: Drug Ineffective, Neutropenia, Leukopenia

Drug(s) suspected as cause:
Epirubicin
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2011-09-06
    End date: 2011-10-18

Cyclophosphamide
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2011-09-06
    End date: 2011-10-18

Fluorouracil
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2011-09-06
    End date: 2011-10-18

Neulasta
    Dosage: 6 mg, unk
    Indication: Chemotherapy
    Start date: 2011-10-19

Other drugs received by patient: Mesna; Dexamethasone; Kevatril



Possible Epirubicin side effects in female

Reported by a physician from Netherlands on 2011-11-03

Patient: female, weighing 90.4 kg (198.9 pounds)

Reactions: Urosepsis, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1040 mg, unk
    Indication: Breast Cancer
    Start date: 2011-05-02

Epirubicin
    Dosage: 2.08 mg, unk
    Indication: Breast Cancer
    Start date: 2011-05-02

NO Treatment Received
    Dosage: no treatment
    Indication: Breast Cancer

Fluorouracil
    Dosage: 1040 mg, unk
    Indication: Breast Cancer
    Start date: 2011-05-02

Other drugs received by patient: Ascal; Hydrochlorothiazide; Omeprazole; Diclofenac; Ascal; Zocor; Enalapril Maleate



Possible Epirubicin side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-01

Patient: 71 year old male

Reactions: Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia

Drug(s) suspected as cause:
Carboplatin
    Dosage: 400 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

Etoposide
    Dosage: 70 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

Fluorouracil
    Dosage: 330 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

Epirubicin
    Dosage: 27 mg/m2, 4-week cycles, completed 6 cycles
    Indication: Metastatic Gastric Cancer

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017